ArticleVaccines2025

Safety and Immunogenicity of Single-Dose of Adsorbed Tetanus Vaccine in Adults Aged 18-44 Years: Randomized, Double-Blind, Positive-Controlled Phase I/III Clinical Trial.

Zhiqiang Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.